NAS:TVTX (USA) Also Trade In: Germany

Travere Therapeutics Inc $ 26.95 0.61 (2.32%)

Volume:
436,280
Avg Vol (1m):
695,069
Market Cap $:
1.62 Bil
Enterprise Value $:
1.48 Bil
PE Ratio:
0.00
PB Ratio:
6.54
Warning! GuruFocus has detected 3 Severe warning signs with TVTX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Travere Therapeutics Inc () from 2003 to Mar 05 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Travere Therapeutics stock (TVTX) PE ratio as of Mar 05 2021 is 0. More Details

Travere Therapeutics PE Ratio (TTM) Chart

EMBED

Travere Therapeutics PE Ratio (TTM) Historical Data

Total 1244
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Travere Therapeutics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-03-050.0 2020-12-300.0
2021-03-040.0 2020-12-290.0
2021-03-030.0 2020-12-280.0
2021-03-020.0 2020-12-240.0
2021-03-010.0 2020-12-230.0
2021-02-260.0 2020-12-220.0
2021-02-250.0 2020-12-210.0
2021-02-240.0 2020-12-180.0
2021-02-230.0 2020-12-170.0
2021-02-220.0 2020-12-160.0
2021-02-190.0 2020-12-150.0
2021-02-180.0 2020-12-140.0
2021-02-170.0 2020-12-110.0
2021-02-160.0 2020-12-100.0
2021-02-150.0 2020-12-090.0
2021-02-120.0 2020-12-080.0
2021-02-110.0 2020-12-070.0
2021-02-100.0 2020-12-040.0
2021-02-090.0 2020-12-030.0
2021-02-080.0 2020-12-020.0
2021-02-050.0 2020-12-010.0
2021-02-040.0 2020-11-300.0
2021-02-030.0 2020-11-270.0
2021-02-020.0 2020-11-250.0
2021-02-010.0 2020-11-240.0
2021-01-290.0 2020-11-230.0
2021-01-280.0 2020-11-200.0
2021-01-270.0 2020-11-190.0
2021-01-260.0 2020-11-180.0
2021-01-250.0 2020-11-170.0
2021-01-220.0 2020-11-160.0
2021-01-210.0 2020-11-130.0
2021-01-200.0 2020-11-120.0
2021-01-190.0 2020-11-110.0
2021-01-150.0 2020-11-100.0
2021-01-140.0 2020-11-090.0
2021-01-130.0 2020-11-060.0
2021-01-120.0 2020-11-050.0
2021-01-110.0 2020-11-040.0
2021-01-080.0 2020-11-030.0
2021-01-070.0 2020-11-020.0
2021-01-060.0 2020-10-300.0
2021-01-050.0 2020-10-290.0
2021-01-040.0 2020-10-280.0
2020-12-310.0 2020-10-270.0

Travere Therapeutics PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325411 NAICS : 2834
Traded in other countries 17R.Germany TVTX.USA
Address 3611 Valley Centre Drive, Suite 300, San Diego, CA, USA, 92130
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases.